Research News
Catch up on the latest news from across the ataxia research world right here.
If you are interested in taking part in research, please click here for current opportunities. If you would like to find out about the research we are currently funding, please click here.
For other enquiries, or if you can’t find information on the type of ataxia you have, please contact our Helpline by emailing help@ataxia.org.uk or calling 0800 995 6037 (opening hours Monday-Thursday 10.30am-2.30pm).
FDA approves Omav
Sign up to a dedicated newsletter and receive the latest news about Reata's SKYCLARYS (Omav) treatment for adults with Friedreich’s ataxia.
All ()
Friedreich's ataxia ()
Friedreich's ataxia pharma news ()
SCAs ()
Cerebellar ataxia pharma news ()
ICAR 2022 ()
Cerebellar ataxia ()
Research News Archive ()
DRPLA ()
Intrabio announces FDA approval of their drug Levacetylleucine (Aqneursa) for the treatment of Niemann-Pick Disease Type C
Cerebellar ataxia, Cerebellar ataxia pharma news, Research News, SCAs, ataxia pharma, Ataxia Pharma news, ataxia research, Ataxia Research News, cerebellar ataxia, Cerebellar ataxia news, cerebellar ataxia pharma, Cerebellar Ataxia Pharma News, Intrabio0Biohaven announces positive results in their study of Troriluzole for Spinocerebellar ataxia (SCA)
Cerebellar ataxia, Cerebellar ataxia pharma news, Research News, SCAs, ataxia pharma, ataxia research, Ataxia Research News, Biohaven, cerebellar ataxia, cerebellar ataxia pharma, Cerebelllar Ataxia Pharma News, SCAs, Troriluzole0Vico Therapeutics announces positive interim data in their phase 1/2a trial of VO659, which is being tested in people with Huntington’s disease (HD) and spinocerebellar ataxias 1 and 3
Cerebellar ataxia, Cerebellar ataxia pharma news, Research News, SCAs, Ataxia Trial, cerebellar ataxia, cerebellar ataxia pharma, Huntington's Disease, SCAs, Vico Therapeutics0Satisfaction is significantly higher in those attending UK specialist ataxia centres compared with those who do not, new paper shows
Cerebellar ataxia, DRPLA, Friedreich's ataxia, Research News, SCAs, spastic ataxias, Ataxia Centres, ataxia research, ataxia survey, cerebellar ataxia, Friedreich's ataxia0Ataxia UK hosts Webinar on UK approval process for Skyclarys in adults with FA
Friedreich's ataxia, Friedreich's ataxia pharma news, OMAV updates, Research News, ataxia research, Ataxia UK Webinar, Friedreich's ataxia, Friedreich's ataxia news, Friedreich's ataxia research, OMAV updates, Omaveloxolone0Lexeo announces positive results from their phase 1/2 clinical trial programme for FA cardiomyopathy
Friedreich's ataxia, Friedreich's ataxia pharma news, Research News, Ataxia Gene Therapy, ataxia research, Ataxia Research News, Friedreich's ataxia, Friedreich's Ataxia Gene Therapy, Friedreich's ataxia news, Friedreich's ataxia pharma, Friedreich's ataxia research, gene therapy, Lexeo Therapeutics, LX20060Ataxia UK hosts an educational webinar on the UK medicines approval process
Ataxia UK news, Cerebellar ataxia, Cerebellar ataxia pharma news, DRPLA, Friedreich's ataxia, Friedreich's ataxia pharma news, Latest News, Research News, SCAs, spastic ataxias, ataxia pharma, ataxia research, Ataxia UK Webinar, Cerebellar Ataxias, Friedreich's ataxia, Medicines Approvals3In conversation with Dr. Federico Herrera, Group Leader of the Cell Structure and Dynamics (CSD) Lab from the Biosystems and Integrative Sciences Institute (BioISI) at the Faculty of Sciences of the University of Lisbon (Ciências ULisboa).
Cerebellar ataxia, Research News, spastic ataxias, ataxia research, Ataxia Research News, Spastic Ataxia Type-8, Spastic Ataxias0Alterity Therapeutics presents data on the potential of ATH434 to treat FA
Cerebellar ataxia, Cerebellar ataxia pharma news, Friedreich's ataxia, Friedreich's ataxia pharma news, Research News, Alterity Therapeutics, ataxia research, Ataxia Research News, Friedreich's ataxia, Friedreich's ataxia pharma, MSA, MSA pharma0Paper published on study of effectiveness of omaveloxolone for Friedreich’s ataxia using natural history study data
Friedreich's ataxia, Friedreich's ataxia pharma news, OMAV updates, Research News, Research News Archive, Friedreich's ataxia, Friedreich's ataxia pharma news, Friedreich's ataxia research, Natural History Study, Omaveloxolone, Skyclarys0Loading...
